West Virginia 2025 Regular Session Status: Enacted 1 R cosponsors

HB 3434 — Relating to the controlled substance schedules and to clean-up errors identified in the code sections

Last action — Chapter 62, Acts, Regular Session, 2025

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed House of Delegates
  4. ✓
    Passed Senate
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced March 17, 2025. Enacted.

Signed by Governor Patrick Morrisey (Republican) on July 22, 2025.

Odds of enactment

High chance

Based on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Advancing 56% · moderate confidence

  • Enacted

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (1 R).

  • Mixed recorded votes

    2 passed, 1 failed in recorded votes so far.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Bill Text

What changed in the latest version

276 added · 256 removed

Plain-language change summary

The recent amendment to Bill HB 3434 includes the addition of specific substances to the list of controlled substances, such as Norfentanyl and Ibogaine, while also maintaining provisions for lawful products manufactured under certain chapters of West Virginia law. This change aims to keep up with emerging drug trends and ensure public safety by regulating newer substances that may pose a risk. It matters because it helps law enforcement manage and prevent the misuse of potentially dangerous drugs in the community.

→
Previous
Latest
WEST VIRGINIA LEGISLATURE REGULAR SESSION ENGROSSED House Bill 3434 By Delegate Kelly (By Request of the Department of Homeland Security – West Virginia State Police) [Introduced March 17, 2025;
WEST VIRGINIA LEGISLATURE REGULAR SESSION ENROLLED House Bill 3434 B YDELEGATE KELLY (BYREQUEST OF THEDEPARTMENT OFHOMELAND SECURITY – WESTVIRGINIS TATEPOLIC) [Passed April 11, 2025;
referred to the Committee on the Judiciary] Eng HB 3434 A BILL to amend and reenact §60A-2-204, §60A-2-206, §60A-2-208, §60A-2-210, and §60A-2- 212 of the Code of West Virginia, 1931, as amended, relating to the controlled substance schedules and to clean-up errors identified in the code sections.
in effect 90 days from passage (July 10, 2025)] Enr HB 3434 AN ACT to amend and reenact §60A-2-204, §60A-2-206, §60A-2-208, §60A-2-210, and §60A-2- 212 of the Code of West Virginia, 1931, as amended, relating to the controlled substance schedules and to clean-up errors identified in the code sections.
Eng HB 3434 Beta-hydroxyfentanyl(N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N- phenylpropanamide);
Enr HB 3434 Beta-hydroxyfentanyl(N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N- phenylpropanamide);
Eng HB 3434 Hydroxypethidine;
Enr HB 3434 Hydroxypethidine;
Norfentanyl (N-Phenyl-N-4-piperidinyl-propanamide);
Eng HB 3434 Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide);
Enr HB 3434 Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide);
Eng HB 3434 Thebacon.
Enr HB 3434 Thebacon.
1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names: para-methoxymethamphetamine, PMMA);
1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names:
para-methoxymethamphetamine, PMMA);
Eng HB 3434 3,4-methylenedioxy-N-ethylamphetamine (also known as ( ethyl-alpha-methyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA, MDE, MDEA);
Enr HB 3434 3,4-methylenedioxy-N-ethylamphetamine (also known as ( ethyl-alpha-methyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA, MDE, MDEA);
7-Ethyl-6, 6 Beta, 7, 8, 9, 10, 12, 13-octahydro-2- methoxy-6, 9-methano-5H- pyrido [1’, 2’:
7-Ethyl-6, 6 Beta, 7, 8, 9, 10, 12, 13-octahydro- 2-methoxy-6, 9-methano-5H- pyrido [1’, 2’:
3-Hexyl -1-hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b,d] pyran;
3-Hexyl -1-hydroxy-7, 8, 9, 10-tetrahydro- 6, 6, 9-trimethyl-6H-dibenzo [b,d] pyran;
Eng HB 3434 Psilocybin;
Enr HB 3434 Psilocybin;
Eng HB 3434 4-methylmethcathinone (Mephedrone);
Enr HB 3434 4-methylmethcathinone (Mephedrone);
Eng HB 3434 (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a- tetrahydrobenzol[c]chromen-1-ol) { also known as HU-211} ;
Enr HB 3434 (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a- tetrahydrobenzol[c]chromen-1-ol) { also known as HU-211} ;
Eng HB 3434 HU-211, (dexanabinol, (6AS,10AS)-9-(hydroxymethyl)-6,6-Dimethyl-3-(2-methyloctan-2- YL)-6A,7,10,10atetrahydrobenzo[ C]chromen-1-OL);
Enr HB 3434 HU-211, (dexanabinol, (6AS,10AS)-9-(hydroxymethyl)-6,6-Dimethyl-3-(2-methyloctan-2- YL)-6A,7,10,10atetrahydrobenzo[ C]chromen-1-OL);
JWH-250, 1-pentyl-3-(2-methoxyphenylacetyl)indole.] Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbu(5F-ate ADB);
JWH-250, 1-pentyl-3-(2-methoxyphenylacetyl)indole.] Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylb(5F-oate ADB);
Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (MDMB- FUBINACA);
Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (MDMB-FUBINACA);
Synthetic Phenethylamines 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanam(25I-NBOMe/ 2C-I- NBOMe);
Synthetic Phenethylamines 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethana(25I-NBOMe/ 2C-I- NBOMe);
Eng HB 3434 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe/2C-C- NBOMe);
Enr HB 3434 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe/2C-C- NBOMe);
N-[1-[2-hydroxy-2-(thiophen-2-yl)ethylpiperidin-4-yl]-N-phenylpropionamide, also known as N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamid(beta- hydroxythiofentanyl);
N-[1-[2-hydroxy-2-(thiophen-2-yl)ethylpiperidin-4-yl]-N-phenylpropionamide, also known as N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide(beta- hydroxythiofentanyl);
Eng HB 3434 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (etodesnitazene);
Enr HB 3434 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (etodesnitazene);
2-(4-ethoxybenzyl)5-nitro-1-(2-(pyrrolidin-1-yl)H-benzimidazole (N-pyrrolidino etonitazene, etonitazepyne);
2-(4-ethoxybenzyl)5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1 H-benzimidazole (N-pyrrolidino etonitazene, etonitazepyne);
Opioid Receptor Agonist 2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one) AH-7921 (3,4-dichloro-N-(1dimethylamino)cyclohexylmethyl]benzamide).
Opioid Receptor Agonist 2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one) AH-7921 (3,4-dichloro-N-(1dimethylamino)cyclohexylmethyl]benzamide).
Eng HB 3434 JWH 015;
Enr HB 3434 JWH 015;
Phenylacetylindoles or any compound containing a 3- Phenylacetylindole structure with substitution at the nitrogen atom of the indole ring whether or not further substituted in the indole Eng HB 3434 ring to any extent and whether or not substituted in the phenyl ring to any extent.
Phenylacetylindoles or any compound containing a 3- Phenylacetylindole structure with substitution at the nitrogen atom of the indole ring whether or not further substituted in the indole Enr HB 3434 ring to any extent and whether or not substituted in the phenyl ring to any extent.
Eng HB 3434 Adamantoylindoles or any compound containing a 3-(-1-Adamantoyl) indole structure with substitution at the nitrogen atom of the indole ring whether or not further substituted in the adamantoyl ring system to any extent.
Enr HB 3434 Adamantoylindoles or any compound containing a 3-(-1-Adamantoyl) indole structure with substitution at the nitrogen atom of the indole ring whether or not further substituted in the adamantoyl ring system to any extent.
FDU-PB-22 (1-Naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate);
Enr HB 3434 FDU-PB-22 (1-Naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate);
Eng HB 3434 FUB-PB-22 (Quinolin-8-yl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate);
FUB-PB-22 (Quinolin-8-yl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate);
Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4 H-[1,2,4]triazolo[4,3- a][1,4]benzodiazepine);
Enr HB 3434 Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4 H-[1,2,4]triazolo[4,3- a][1,4]benzodiazepine);
Eng HB 3434 Cloniprazepam (5-(2-chlorophenyl)-1-(cyclopropylmethyl)-1,3-dihydro-7-nitro-2H-1,4- benzodiazepin-2-one);
Cloniprazepam (5-(2-chlorophenyl)-1-(cyclopropylmethyl)-1,3-dihydro-7-nitro-2H-1,4- benzodiazepin-2-one);
Methaqualone;
Enr HB 3434 Methaqualone;
Eng HB 3434 Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4 H-[1,2,4]triazolo[4,3 a][1,4]benzodiazepine);
Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4 H-[1,2,4]triazolo[4,3 a][1,4]benzodiazepine);
Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-[1,2,4]triazolo[4,3- a][1,4]diazepine);
Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f[1,2,4]triazolo[4,3- a][1,4]diazepine);
4- hydroxybutyrate;
4-hydroxybutyrate;
Declazepam Diclazepam (7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4- benzodiazepin-2-one);
Diclazepam (7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2- one);
(f) Stimulants.
Enr HB 3434 (f) Stimulants.
Eng HB 3434 Aminorex;
Aminorex;
4,4'-Dimethylaminorex (4,4′-DMAR;
4,4'-Dimethylaminorex(4,4′-DMAR;
Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate);
Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate);
Show all 83 changed rows (43 more)
Previous
Latest
 Mesocarb (N-phenyl-N ′-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate);
Mesocarb (N-phenyl-N ′-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate);
2-chloroamphetamine;
Enr HB 3434 2-chloroamphetamine;
Eng HB 3434 3-chloroamphetamine;
3-chloroamphetamine;
Eng HB 3434 Methoxyacetyl fentanyl (2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]- acetamide);
Enr HB 3434 Methoxyacetyl fentanyl (2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]- acetamide);
or Any other synthetic chemical compound that is a Cannabinoid receptor type 1 agonist as demonstrated by binding studies and functional assays that is not listed in Schedules II, III, IV, and Eng HB 3434 V, not federal Food and Drug Administration approved drug or used within legitimate, approved medical research.
or Any other synthetic chemical compound that is a Cannabinoid receptor type 1 agonist as demonstrated by binding studies and functional assays that is not listed in Schedules II, III, IV, Enr HB 3434 and V, not federal Food and Drug Administration approved drug or used within legitimate, approved medical research.
Eng HB 3434 Hydrocodone;
Enr HB 3434 Hydrocodone;
Eng HB 3434 Dihydrocodeine;
Enr HB 3434 Dihydrocodeine;
and Eng HB 3434 Thiafentanil (4-(methoxycarbonyl)-4-(N-phenmethoxyacetamido)-1-2- (thienyl)ethylpiperidine), including its isomers, esters, ethers, salts and salts of isomers, esters and ethers.
and Enr HB 3434 Thiafentanil (4-(methoxycarbonyl)-4-(N-phenmethoxyacetamido)-1-2- (thienyl)ethylpiperidine), including its isomers, esters, ethers, salts and salts of isomers, esters and ethers.
Eng HB 3434 Some trade or other names:
Enr HB 3434 Some trade or other names:
Eng HB 3434 (c) Depressants.
Enr HB 3434 (c) Depressants.
(+- )-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone];
(+-)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone];
Eng HB 3434 (14) Methyprylon;
Enr HB 3434 (14) Methyprylon;
(15) Perampanel, and its salts, isomers, and salts of isomers;
(15) Perampanel, and its salts, isomers, and salts of isomers;
(15)(16) Sulfondiethylmethane;
(16) Sulfondiethylmethane;
(16)(17) Sulfonethylmethane;
(17) Sulfonethylmethane;
(17)(18) Sulfonmethane;
(18) Sulfonmethane;
(18)(19) Thiamylal;
(19) Thiamylal;
(19)(20) Thiopental;
(20) Thiopental;
(20) (21)Tiletamine and zolazepam or any salt of tiletamine and zolazepam;
(21)Tiletamine and zolazepam or any salt of tiletamine and zolazepam;
and (21)(22) Vinbarbital.
and (22) Vinbarbital.
Eng HB 3434 (D) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
Enr HB 3434 (D) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
(6aR-trans)-6a, 7, 8, 10a- tetrahydro-6, 6, 9-trimethyl-3-pentyl-6H-dibenzo [b,d] pyran- 1- ol or (-)-delta-9-(trans)-tetrahydrocannabinol).
(6aR-trans)-6a, 7, 8, 10a- tetrahydro-6, 6, 9-trimethyl-3-pentyl-6H-dibenzo [b,d] pyran-1- ol or (-)-delta-9-(trans)-tetrahydrocannabinol).
Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or Eng HB 3434 preparation which contains any quantity of the following substances, including their isomers, esters, ethers, salts and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation.
Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or Enr HB 3434 preparation which contains any quantity of the following substances, including their isomers, esters, ethers, salts and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation.
Eng HB 3434 Daridorexant;
Enr HB 3434 Daridorexant;
Eng HB 3434 Nitrazepam;
Enr HB 3434 Nitrazepam;
Eng HB 3434 Fencamfamin;
Enr HB 3434 Fencamfamin;
Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or Eng HB 3434 preparation which contains any quantity of the following substances, including their isomers, esters, ethers, salts and salts of isomers, esters and ethers, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation.
Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or Enr HB 3434 preparation which contains any quantity of the following substances, including their isomers, esters, ethers, salts and salts of isomers, esters and ethers, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation.
(d) Any compound, mixture, or preparation containing as its single active ingredient ephedrine, pseudoephedrine, or phenylpropanolamine, their salts or optical isomers, or salts of optical isomers except products which are for pediatric use primarily intended for administration to children under the age of 12: Provided, That neither the offenses set forth in section four hundred one, article four of this chapter, nor the penalties therein, shall be applicable to ephedrine, pseudoephedrine or phenylpropanolamine which shall be subject to the provisions of article ten of this chapter.
(d) Any compound, mixture, or preparation containing as its single active ingredient ephedrine, pseudoephedrine, or phenylpropanolamine, their salts or optical isomers, or salts of optical isomers except products which are for pediatric use primarily intended for administration to children under the age of 12:
Eng HB 3434 (e) Depressants:
Provided, That neither the offenses set forth in section four hundred one, article fourof this chapter, nor the penalties therein, shall be applicable to ephedrine, pseudoephedrine or phenylpropanolamine which shall be subject to the provisions of article ten of this chapter.
Enr HB 3434 (e) Depressants:
Ganaxolone (3α-hydroxy-3β-methyl-5α-pregnan-20-one);
Ganaxolone (3α-hydroxy-3β-methyl-5α-pregnan-20-one);
35
Enr HB 3434 The Clerk of the House of Delegates and the Clerk of the Senate hereby certify that the foregoing bill is correctly enrolled.
...............................................................
Clerk of the House of Delegates ...............................................................
Clerk of the Senate Originated in the House of Delegates.
In effect 90 days from passage.
...............................................................
Speaker of the House of Delegates ...............................................................
President of the Senate __________ The within is ................................................
this the...........................................
Day of ..........................................................................................................., 2025.
.............................................................
Governor 37
⬇ Download PDF
View plain text versions (3)

Action History

  1. Chapter 62, Acts, Regular Session, 2025

  2. Approved by Governor 4/25/2025

  3. To Governor 4/21/2025

  4. Approved by Governor 4/25/2025 - Senate Journal

  5. Approved by Governor 4/25/2025 - House Journal

  6. To Governor 4/21/2025 - Senate Journal

  7. To Governor 4/21/2025 - House Journal

  8. Completed legislative action

  9. Communicated to House

  10. Passed Senate (Roll No. 505)

  11. Read 3rd time

  12. On 3rd reading

  13. Read 2nd time

  14. Immediate consideration

  15. Reported do pass

  16. On second reading, rereferred to Judiciary

  17. Read 1st time

  18. Immediate consideration

  19. Without recommendation, but first rereferred to Judiciary

  20. To Judiciary

  21. To Judiciary

  22. Introduced in Senate

  23. Communicated to Senate

  24. Passed House (Roll No. 222)

  25. Read 3rd time

  26. On 3rd reading, Special Calendar

  27. Amendment rejected (Roll No. 201)

  28. Amendment reported by the Clerk

  29. Read 2nd time

  30. On 2nd reading, Special Calendar

  31. Read 1st time

  32. On 1st reading, Special Calendar

  33. Do pass

  34. Markup Discussion

  35. To House Judiciary

  36. Introduced in House

  37. To Judiciary

  38. Filed for introduction

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 151 not signed on · 70 voted No

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (151)

151 members have not signed on to this bill.

Show all 151 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Passage

Passed 34 Yea · 0 Nay
Party YeaNayPresentNot Voting
Republican 29000
Unaffiliated 3000
Democrat 2000
Total 34000
% of votes cast 100%0%0%0%
How each member voted (34)
Member Party Vote
STUART — Yea
BOLEY — Yea
MR PRESIDENT — Yea
Joey Garcia Democrat Yea
Mike Woelfel Democrat Yea
Amy Grady Republican Yea
Anne B. Charnock Republican Yea
Ben Queen Republican Yea
Bill Hamilton Republican Yea
Brian Helton Republican Yea
Charles H. Clements Republican Yea
Chris Rose Republican Yea
Craig A. Hart Republican Yea
Darren Thorne Republican Yea
Eric Tarr Republican Yea
Glenn Jeffries Republican Yea
Jack Woodrum Republican Yea
Jason Barrett Republican Yea
Jay Taylor Republican Yea
Laura Wakim Chapman Republican Yea
Mark R. Maynard Republican Yea
Mike Azinger Republican Yea
Mike Oliverio Republican Yea
Patricia Rucker Republican Yea
Patrick Martin Republican Yea
Robbie Morris Republican Yea
Rollan A. Roberts Republican Yea
Rupie Phillips Republican Yea
Ryan Weld Republican Yea
Scott Fuller Republican Yea
T. Kevan Bartlett Republican Yea
Tom Takubo Republican Yea
Tom Willis Republican Yea
Vince Deeds Republican Yea

Official roll call →

PASSAGE

Passed 89 Yea · 3 Nay · 8 Other
Party YeaNayPresentNot Voting
Republican 78205
Unaffiliated 4101
Democrat 7002
Total 89308
% of votes cast 89%3%0%8%
How each member voted (100)
Member Party Vote
Devault — Yea
Kump — Yea
Steele — Yea
Flanigan — Nay
Linville — Not Voting
Clark, T — Yea
Anitra Hamilton Democrat Yea
Evan Hansen Democrat Yea
Hollis Lewis Democrat Yea
John Williams Democrat Not Voting
Kayla Young Democrat Yea
Mike Pushkin Democrat Yea
Rick Garcia Democrat Yea
Sean Hornbuckle Democrat Not Voting
Shawn Fluharty Democrat Yea
Adam Burkhammer Republican Yea
Adam Vance Republican Yea
Andy Shamblin Republican Yea
Betsy Kelly Republican Yea
Bill Ridenour Republican Yea
Bob Fehrenbacher Republican Yea
Bryan Smith Republican Yea
Bryan Ward Republican Yea
Carl "Bill" Roop Republican Yea
Carl Martin Republican Yea
Charles Sheedy Republican Yea
Chris Phillips Republican Yea
Christopher W. Toney Republican Yea
Chuck Horst Republican Yea
Clay Riley Republican Not Voting
D. Rolland Jennings Republican Yea
Dana Ferrell Republican Yea
Dave Foggin Republican Yea
David Cannon Republican Yea
David Green Republican Yea
David McCormick Republican Yea
Dean Jeffries Republican Yea
Doug Smith Republican Yea
Elias Coop-Gonzalez Republican Yea
Eric Brooks Republican Yea
Erica Moore Republican Not Voting
Evan Worrell Republican Yea
Gary G. Howell Republican Yea
Geno Chiarelli Republican Yea
George Miller Republican Yea
George Street Republican Yea
Henry Dillon Republican Nay
Ian T. Masters Republican Yea
James Robert "JB" Akers II Republican Yea
Jarred Cannon Republican Yea
Jeff Campbell Republican Yea
Jeff Eldridge Republican Yea
Jeffrey Stephens Republican Yea
Jim Butler Republican Yea
Jimmy Willis Republican Yea
Joe Ellington Republican Yea
Joe Funkhouser Republican Yea
Joe Parsons Republican Yea
Joe Statler Republican Yea
John Paul Hott Republican Yea
Jonathan Kyle Republican Yea
Jonathan Pinson Republican Yea
Jordan Bridges Republican Yea
Jordan Maynor Republican Yea
Josh Holstein Republican Yea
Kathie Hess Crouse Republican Yea
Keith Marple Republican Yea
Laura Kimble Republican Yea
Lisa White Republican Yea
Lori Dittman Republican Yea
Margitta Mazzocchi Republican Yea
Mark Dean Republican Yea
Mark Zatezalo Republican Yea
Marshall W. Clay Republican Yea
Marty Gearheart Republican Yea
Matthew Rohrbach Republican Yea
Michael Amos Republican Yea
Michael Hite Republican Yea
Michael Hornby Republican Yea
Mickey Petitto Republican Yea
Pat McGeehan Republican Yea
Patrick Lucas Republican Not Voting
Phil Mallow Republican Yea
Ray Canterbury Republican Yea
Rick Hillenbrand Republican Yea
Roger Hanshaw Republican Not Voting
Roy Cooper Republican Yea
Ryan Browning Republican Yea
S. Chris Anders Republican Nay
Sarah Drennan Republican Not Voting
Scot C. Heckert Republican Yea
Stanley Adkins Republican Yea
Trenton Barnhart Republican Yea
Tresa Howell Republican Yea
Tristan Leavitt Republican Yea
Vacant1 Republican Yea
Vernon Criss Republican Yea
Walter Hall Republican Yea
Wayne Clark Republican Yea
William Anderson Republican Yea

Official roll call →

HFA PUSHKIN 3-26

Failed 20 Yea · 71 Nay · 9 Other
Party YeaNayPresentNot Voting
Republican 106906
Democrat 8001
Unaffiliated 2202
Total 207109
% of votes cast 20%71%0%9%
How each member voted (100)
Member Party Vote
Steele — Yea
Flanigan — Yea
Devault — Nay
Linville — Not Voting
Kump — Not Voting
Clark, T — Nay
Anitra Hamilton Democrat Yea
Evan Hansen Democrat Yea
Hollis Lewis Democrat Yea
John Williams Democrat Yea
Kayla Young Democrat Not Voting
Mike Pushkin Democrat Yea
Rick Garcia Democrat Yea
Sean Hornbuckle Democrat Yea
Shawn Fluharty Democrat Yea
Adam Burkhammer Republican Nay
Adam Vance Republican Nay
Andy Shamblin Republican Nay
Betsy Kelly Republican Nay
Bill Ridenour Republican Nay
Bob Fehrenbacher Republican Nay
Bryan Smith Republican Nay
Bryan Ward Republican Not Voting
Carl "Bill" Roop Republican Nay
Carl Martin Republican Not Voting
Charles Sheedy Republican Nay
Chris Phillips Republican Nay
Christopher W. Toney Republican Nay
Chuck Horst Republican Nay
Clay Riley Republican Nay
D. Rolland Jennings Republican Not Voting
Dana Ferrell Republican Nay
Dave Foggin Republican Yea
David Cannon Republican Nay
David Green Republican Nay
David McCormick Republican Nay
Dean Jeffries Republican Nay
Doug Smith Republican Yea
Elias Coop-Gonzalez Republican Nay
Eric Brooks Republican Nay
Erica Moore Republican Nay
Evan Worrell Republican Nay
Gary G. Howell Republican Nay
Geno Chiarelli Republican Nay
George Miller Republican Nay
George Street Republican Not Voting
Henry Dillon Republican Nay
Ian T. Masters Republican Yea
James Robert "JB" Akers II Republican Nay
Jarred Cannon Republican Nay
Jeff Campbell Republican Nay
Jeff Eldridge Republican Yea
Jeffrey Stephens Republican Nay
Jim Butler Republican Nay
Jimmy Willis Republican Nay
Joe Ellington Republican Nay
Joe Funkhouser Republican Nay
Joe Parsons Republican Nay
Joe Statler Republican Nay
John Paul Hott Republican Nay
Jonathan Kyle Republican Nay
Jonathan Pinson Republican Nay
Jordan Bridges Republican Not Voting
Jordan Maynor Republican Nay
Josh Holstein Republican Nay
Kathie Hess Crouse Republican Nay
Keith Marple Republican Nay
Laura Kimble Republican Nay
Lisa White Republican Yea
Lori Dittman Republican Nay
Margitta Mazzocchi Republican Nay
Mark Dean Republican Yea
Mark Zatezalo Republican Not Voting
Marshall W. Clay Republican Nay
Marty Gearheart Republican Nay
Matthew Rohrbach Republican Nay
Michael Amos Republican Nay
Michael Hite Republican Nay
Michael Hornby Republican Nay
Mickey Petitto Republican Yea
Pat McGeehan Republican Nay
Patrick Lucas Republican Nay
Phil Mallow Republican Nay
Ray Canterbury Republican Yea
Rick Hillenbrand Republican Nay
Roger Hanshaw Republican Nay
Roy Cooper Republican Nay
Ryan Browning Republican Nay
S. Chris Anders Republican Yea
Sarah Drennan Republican Nay
Scot C. Heckert Republican Nay
Stanley Adkins Republican Nay
Trenton Barnhart Republican Nay
Tresa Howell Republican Nay
Tristan Leavitt Republican Nay
Vacant1 Republican Yea
Vernon Criss Republican Nay
Walter Hall Republican Nay
Wayne Clark Republican Nay
William Anderson Republican Nay

Official roll call →

Subjects

public-safety healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HB 3434?
HB 3434 is sponsored by Betsy Kelly (Republican).
What is the current status of HB 3434?
This bill has been enacted into law. Introduced March 17, 2025. Enacted.
Where can I track HB 3434?
Track HB 3434 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 3434

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 3434

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →